We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+4.1%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$946M
AUM Growth
+$84.3M
(+9.8%)
Cap. Flow
+$58.4M
Cap. Flow
% of AUM
6.17%
Top 10 Holdings %
Top 10 Hldgs %
5.74%
Holding
1,852
New
717
Increased
240
Reduced
255
Closed
635
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$5.94M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$5.81M |
| 3 |
Xcel Energy
XEL
|
+$5.01M |
| 4 |
General Mills
GIS
|
+$4.97M |
| 5 |
AbbVie
ABBV
|
+$4.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$7.75M |
| 2 |
United Parcel Service
UPS
|
+$4.82M |
| 3 |
Yum! Brands
YUM
|
+$4.38M |
| 4 |
ConocoPhillips
COP
|
+$3.98M |
| 5 |
DuPont de Nemours
DD
|
+$3.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.69% |
| 2 | Consumer Discretionary | 14.91% |
| 3 | Industrials | 14.15% |
| 4 | Technology | 11.51% |
| 5 | Healthcare | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
ArcBest
ARCB
$3.33B
| $311K | 0.03% |
+3,144
| New | +$281K |
|
752
German American Bancorp
GABC
$1.92B
| $308K | 0.03% |
+11,329
| New | +$330K |
|
|
RYZ
753
Ryerson Holding Corp
RYZ
$1.61B
| $308K | 0.03% |
+7,092
| New | +$263K |
|
754
CACI
CACI
$11.3B
| $307K | 0.03% |
902
-299
| -25% | -$92.9K |
|
755
Mid-America Apartment Communities
MAA
$15.8B
| $306K | 0.03% |
2,017
-5,589
| -73% | -$840K |
|
756
United Microelectronic
UMC
$43.6B
| $306K | 0.03% |
38,815
-74,165
| -66% | -$611K |
|
757
Americold
COLD
$4.17B
| $306K | 0.03% |
9,478
-12,192
| -56% | -$363K |
|
758
Guardant Health
GH
$19B
| $306K | 0.03% |
8,548
-15,692
| -65% | -$451K |
|
|
PPLI
759
People Inc
PPLI
$3.13B
| $305K | 0.03% |
5,918
-744
| -11% | -$34.1K |
|
760
Outset Medical
OM
$87.5M
| $305K | 0.03% |
929
-327
| -26% | -$99.7K |
|
761
Riot Platforms
RIOT
$8.03B
| $303K | 0.03% |
25,649
-25,102
| -49% | -$281K |
|
762
Goosehead Insurance
GSHD
$1.63B
| $302K | 0.03% |
+4,798
| New | +$276K |
|
763
LCI Industries
LCII
$2.62B
| $301K | 0.03% |
2,380
+113
| +5% | +$12.9K |
|
764
Howard Hughes
HHH
$4B
| $300K | 0.03% |
+3,992
| New | +$289K |
|
765
Silicon Laboratories
SLAB
$7.17B
| $300K | 0.03% |
+1,901
| New | +$287K |
|
|
TWO
766
Two Harbors Investment
TWO
$1.27B
| $300K | 0.03% |
+21,582
| New | +$285K |
|
767
CTS Corp
CTS
$1.85B
| $299K | 0.03% |
+7,020
| New | +$309K |
|
768
Agnico Eagle Mines
AEM
$71.9B
| $299K | 0.03% |
5,984
-14,401
| -71% | -$779K |
|
769
iShares MSCI USA Quality Factor ETF
QUAL
$46.2B
| $298K | 0.03% |
2,213
-5,867
| -73% | -$746K |
|
770
Endava
DAVA
$153M
| $298K | 0.03% |
+5,756
| New | +$309K |
|
|
KW
771
DELISTED
Kennedy-Wilson Holdings
KW
| $298K | 0.03% |
+18,224
| New | +$291K |
|
772
AtriCure
ATRC
$2.01B
| $297K | 0.03% |
+6,019
| New | +$277K |
|
773
Pfizer
PFE
$144B
| $296K | 0.03% |
8,067
-35,466
| -81% | -$1.38M |
|
774
Zscaler
ZS
$24.5B
| $296K | 0.03% |
2,020
-13,999
| -87% | -$1.71M |
|
775
Skyworks Solutions
SWKS
$9.73B
| $294K | 0.03% |
2,653
-1,618
| -38% | -$171K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q2 2023 Portfolio in Review
As of Q2 2023, Y-Intercept (HK) held 1,852 positions worth $946M, up 9.8% from $861M the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
Y-Intercept (HK) deployed $58.4M of net new capital in Q2 2023, opening 717 new positions and adding to 240 existing holdings. Its largest new stake was Union Pacific: 29,892 shares worth $6.12M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was ConocoPhillips, an estimated $3.98M trimmed.
- Y-Intercept (HK)'s largest Q2 2023 buy was Union Pacific: 29,892 shares worth $6.12M.
- Y-Intercept (HK) added most to Blackstone in Q2 2023, an estimated $4.36M increase.
- Y-Intercept (HK)'s biggest Q2 2023 reduction was ConocoPhillips, cutting an estimated $3.98M.
- Y-Intercept (HK) fully exited Cigna in Q2 2023, selling an estimated $7.75M.
- Y-Intercept (HK)'s ten largest holdings make up 5.7% of its $946M portfolio in Q2 2023.
- Y-Intercept (HK) opened 717 new positions and closed 635 in Q2 2023.
- Y-Intercept (HK)'s portfolio value rose 9.8% quarter-over-quarter to $946M.
Based on Y-Intercept (HK)'s 13F filing for Q2 2023, filed 14 Aug 2023.